On Dec. 16, 2020, Pacific Biosciences announced initial findings from the companyﾒs research collaboration with Labcorp that was focused on SARS-CoV-2 and the related immune response to COVID-19. Labcorp used this information to shed light on viral evolution during the early pandemic, mutations arising in different geographic regions, and the implications for disease severity and outcomes.